Asset Allocation

As of March 31, 2026.
Type % Net
Cash 0.35%
Stock 99.06%
Bond 0.38%
Convertible 0.00%
Preferred 0.00%
Other 0.20%
View Asset Allocation
Start Trial

Market Capitalization

As of March 31, 2026
Large 88.21%
Mid 6.49%
Small 5.29%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 95.82%    % Emerging Markets: 3.63%    % Unidentified Markets: 0.55%

Americas 57.99%
57.47%
Canada 3.54%
United States 53.93%
0.52%
Brazil 0.52%
As of March 31, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 25.07%
United Kingdom 5.33%
19.74%
Denmark 1.18%
France 3.69%
Germany 2.83%
Italy 2.44%
Netherlands 1.44%
Spain 4.15%
Switzerland 3.35%
0.00%
0.00%
Greater Asia 16.39%
Japan 6.74%
1.33%
Australia 1.33%
5.21%
Hong Kong 1.00%
South Korea 1.02%
Taiwan 3.19%
3.11%
China 2.64%
India 0.47%
Unidentified Region 0.55%

Stock Sector Exposure

Cyclical
32.21%
Materials
4.00%
Consumer Discretionary
4.81%
Financials
23.41%
Real Estate
0.00%
Sensitive
49.78%
Communication Services
5.08%
Energy
7.84%
Industrials
16.33%
Information Technology
20.53%
Defensive
17.28%
Consumer Staples
4.54%
Health Care
12.74%
Utilities
0.00%
Not Classified
0.73%
Non Classified Equity
0.00%
Not Classified - Non Equity
0.73%
As of March 31, 2026
View Region Exposure
Start Trial

Stock Style Exposure

Large Cap Value --
Large Cap Core --
Large Cap Growth --
Mid Cap Value --
Mid Cap Core --
Mid Cap Growth --
Small Cap Value --
Small Cap Core --
Small Cap Growth --
No Data Available